Status:
COMPLETED
Canadian e-Platform to Promote Behavioral Self-Management in Chronic Heart Failure: CHF-CePPORT
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
Heart and Stroke Foundation of Ontario
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Chronic Heart Failure (CHF) is a growing public health issue in Canada. Hospital re-admission within 1-year after diagnosis is 25-40%, and the 5-year rate of CHF death is 50%. Counseling by multidisci...
Eligibility Criteria
Inclusion
- Male and female patients 18 years of age who are diagnosed with heart failure with reduced ejection fraction ("systolic HF") corresponding to New York Heart Association Class II-III for 3 months prior to enrolment;
- documentation of LVEF 40%;
- subject has access to a personal computer;
Exclusion
- Documentation at enrolment of renal failure, significant liver disease or poorly controlled diabetes mellitus;
- persistent systolic or diastolic hypertension \[systolic \> 170 mmHg or diastolic \> 100 mmHg despite antihypertensive therapy;
- CHF secondary to cardiovascular co-morbidities/procedures;
- previous heart transplant or wait listed for heart transplant at time of enrolment
Key Trial Info
Start Date :
September 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2018
Estimated Enrollment :
248 Patients enrolled
Trial Details
Trial ID
NCT01864369
Start Date
September 1 2013
End Date
July 1 2018
Last Update
July 6 2021
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
St.Paul's Hospital- UBC
Vancouver, British Columbia, Canada, V6Z 1Y6
2
University Health Network
Toronto, Ontario, Canada, M5G 2N2
3
Montreal Heart Institute
Montreal, Quebec, Canada, H1T 1C8